Received Apr 9, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | 425CR | IM / LA |
pregnant patient received Shingrix; vesicular rash on both arms, neck and chest; burning pain similar to sunburn/painful arm; This non-serious prospective pregnancy case was reported by a pharmacist via call center representative and described the occurrence of vesicular rash in a 56-year-old female patient who received Herpes zoster (Shingrix) (batch number 425CR, expiry date 10-AUG-2026) for prophylaxis. On 03-MAR-2025, the patient received the 1st dose of Shingrix (intramuscular, left deltoid). On 14-MAR-2025, 11 days after receiving Shingrix, the patient experienced vesicular rash (Verbatim: vesicular rash on both arms, neck and chest) and pain burning (Verbatim: burning pain similar to sunburn/painful arm). On an unknown date, the patient experienced vaccine exposure during pregnancy (Verbatim: pregnant patient received Shingrix). The outcome of the vesicular rash and pain burning were unknown and the outcome of the vaccine exposure during pregnancy was not applicable. It was unknown if the reporter considered the vesicular rash and pain burning to be related to Shingrix. It was unknown if the company considered the vesicular rash and pain burning to be related to Shingrix. Pregnancy Outcome: Pregnancy was ongoing Additional Information: GSK Receipt Date: 19-MAR-2025 The reporter stated that the patient received her first Shingrix injection in her left deltoid on 3-Mar-2025. On 14-Mar-2025 she presented with a vesicular rash on both arms, neck and chest and the rash was giving her burning pain similar to sunburn. Pregnant patient received Shingrix, which led to vaccine exposure during pregnancy.